Modeling and Simulation of the Immune System as a Self-Regulating Network

Methods in Enzymology

Volumn 467, Issue C, 2009, Pages 79-109

  Kim, Peter S ^a   Levy, Doron ^b   Lee, Peter P ^c  

^a UNIVERSITY OF UTAH   (United States)

^b Bldg 142   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOREGULATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; COMPUTER SIMULATION; IMMUNE SYSTEM; IMMUNOREGULATION; NEGATIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; STOCHASTIC MODEL;

EID: 71549163142     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)67004-X     Document Type: Review

References (60)

1. Antia R., Bergstrom C.T., Pilyugin S.S., Kaech S.M., and Ahmed R. Models of CD8+ responses: 1. What is the antigen-independent proliferation program. J. Theor. Biol. 221 4 (2003) 585-598
2. Arstila T.P., Casrouge A., Baron V., Even J., Kanellopoulos J., and Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science 286 5441 (1999) 958-961
3. Bains I., Antia R., Callard R., and Yates A.J. Quantifying the development of the peripheral naive CD4+ T-cell pool in humans. Blood 113 22 (2009) 5480-5487
4. Bheekha Escura R., Wasserbauer E., Hammerschmid F., Pearce A., Kidd P., and Mudde G.C. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies. Immunology 86 3 (1995) 343-350
5. Böhm C.M., Hanski M.L., Stefanović S., Rammensee H.G., Stein H., Taylor-Papadimitriou J., Riecken E.O., and Hanski C. Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells. Int. J. Cancer 75 5 (1998) 688-693
6. Burroughs N.J., de Oliveira B.M.P.M., and Pinto A.A. Regulatory T cell adjustment of quorum growth thresholds and the control of local immune responses. J. Theor. Biol. 241 (2006) 134-141
7. Carneiro J., Paixão T., Milutinovic D., Sousa J., Leon K., Gardner R., and Faro J. Immunological self-tolerance: Lessons from mathematical modeling. J. Comput. Appl. Math. 184 (2005) 77-100
8. Casadevall A., and Pirofski L.A. The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 1 (2003) 17-24
9. Casadevall A., and Pirofski L.A. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv. Immunol. 91 (2006) 1-44
10. Casal A., Sumen C., Reddy T.E., Alber M.S., and Lee P.P. Agent-based modeling of the context dependency in T cell recognition. J. Theor. Biol. 236 4 (2005) 376-391
11. Catron D.M., Itano A.A., Pape K.A., Mueller D.L., and Jenkins M.K. Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity 21 3 (2004) 341-347
12. Celada F., and Seiden P.E. A computer model of cellular interactions in the immune system. Immunol. Today 13 2 (1992) 56-62
13. Colijn C., and Mackey M.C. A mathematical model of hematopoiesis-II. Cyclical neutropenia. J. Theor. Biol. 237 2 (2005) 133-146
14. De Boer R.J., and Perelson A.S. Size and connectivity as emergent properties of a developing immune network. J. Theor. Biol. 149 3 (1990) 381-424
15. De Boer R.J., Kevrekidis I.G., and Perelson A.S. A simple idiotypic network with complex dynamics. Chem. Eng. Sci. 45 (1990) 2375-2382
16. de Pillis L.G., Radunskaya A.E., and Wiseman C.L. A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res. 65 17 (2005) 7950-7958
17. Doumic-Jauffret M., Kim P.S., and Perthame B. Stability analysis of a simplified yet complete model for chronic myelegenous leukemia. (2009) Submitted for publication
18. Figge M.T. Optimization of immunoglobulin substitution therapy by a stochastic immune response model. PLoS ONE 4 5 (2009) e5685
19. Figge M.T., Garin A., Gunzer M., Kosco-Vilbois M., Toellner K.M., and Meyer-Hermann M. Deriving a germinal center lymphocyte migration model from two-photon data. J. Exp. Med. 205 13 (2008) 3019-3029
20. Folcik V.A., An G.C., and Orosz C.G. The Basic Immune Simulator: An agent-based model to study the interactions between innate and adaptive immunity. Theor. Biol. Med. Model. 4 (2007) 39
21. Fong L., Hou Y., Rivas A., Benike C., Yuen A., Fisher G.A., Davis M.M., and Engleman E.G. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA 98 15 (2001) 8809-8814
22. Fouchet D., and Regoes R. A population dynamics analysis of the interaction between adaptive regulatory T cells and antigen presenting cells. PLoS ONE 3 5 (2008) e2306
23. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pagès C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoué F., Bruneval P., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 5795 (2006) 1960-1964
24. Hackett C.J., Rotrosen D., Auchincloss H., and Fauci A.S. Immunology research: Challenges and opportunities in a time of budgetary constraint. Nat. Immunol. 8 2 (2007) 114-117
25. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18 (2000) 709-737
26. Heyman B. Feedback regulation by IgG antibodies. Immunol. Lett. 88 2 (2003) 157-161
27. Kaech S.M., and Ahmed R. Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in naïve cells. Nat. Immunol. 2 5 (2001) 415-422
28. Kawakami Y., and Rosenberg S.A. Human tumor antigens recognized by T-cells. Immunol. Res. 16 4 (1997) 313-339
29. Kim P.S., Lee P.P., and Levy D. Emergent group dynamics governed by regulatory cells produce a robust primary T cell response. (2009) Accepted by Bull. Math. Biol
30. Kim P.S., Lee P.P., and Levy D. Modeling regulation mechanisms of the immune system. J. Theor. Biol. 246 (2007) 33-69
31. Kim P.S., Lee P.P., and Levy D. Modeling imatinib-treated chronic myelogenous leukemia: Reducing the complexity of agent-based models. Bull. Math. Biol. 70 3 (2008) 728-744
32. Lee H.Y., Topham D.J., Park S.Y., Hollenbaugh J., Treanor J., Mosmann T.R., Jin X., Ward B.M., Miao H., Holden-Wiltse J., Perelson A.S., Zand M., et al. Simulation and prediction of the adaptive immune response to influenza A virus infection. J. Virol. 83 14 (2009) 7151-7165
33. León K., Lage A., and Carneiro J. Tolerance and immunity in a mathematical model of T-cell mediated suppression. J. Theor. Biol. 225 (2003) 107-126
34. León K., Faro J., Lage A., and Carneiro J. Inverse correlation between the incidences of autoimmune disease and infection predicted by a model of T cell mediated tolerance. J. Autoimmun. 22 (2004) 31-42
35. León K., Lage A., and Carneiro J. How regulatory CD25+CD4+ T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors. J. Theor. Biol. 247 (2007) 122-137
36. León K., Lage A., and Carneiro J. How regulatory CD25+CD4+ T cells impinge on tumor immunobiology: The differential response of tumors to therapies. J. Immunol. 179 9 (2007) 5659-5668
37. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19 9 (1998) 395-404
38. Mata J., and Cohn M. Cellular automata-based modeling program: Synthetic immune system. Immunol. Rev. 216 (2007) 198-212
39. Meffre E., and Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr. Opin. Immunol. 20 6 (2008) 632-638
40. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., and Pamer E.G. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165 12 (2000) 6833-6839
41. Merrill S.J. A model of the role of natural killer cells in immune surveillance-I. J. Math. Biol. 12 (1981) 363-373
42. Molldrem J.J., Lee P.P., Wang C., Champlin R.E., and Davis M.M. A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Res. 59 11 (1999) 2675-2681
43. Moore H., and Li N.K. A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction. J. Theor. Biol. 225 4 (2004) 513-523
44. Murakami M., Sakamoto A., Bender J., Kappler J., and Marrack P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 99 13 (1998) 8832-8837
45. Nelson B.H. The impact of T-cell immunity on ovarian cancer outcomes. Immunol. Rev. 222 (2008) 101-116
46. Oka Y., Elisseeva O.A., Tsuboi A., Ogawa H., Tamaki H., Li H., Oji Y., Kim E.H., Soma T., Asada M., Ueda K., Maruya E., et al. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 51 2 (2000) 99-107
47. Onsum M., and Rao C.V. A mathematical model for neutrophil gradient sensing and polarization. PLoS Comput. Biol. 3 3 (2007) e36
48. Pardoll D.M. Inducing autoimmune disease to treat cancer. Proc. Natl. Acad. Sci. USA 96 10 (1999) 5340-5342
49. Rajewsky K. Clonal selection and learning in the antibody system. Nature 381 6585 (1996) 751-758
50. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature 411 6835 (2001) 380-384
51. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 3 (1995) 1151-1164
52. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 5 (2008) 775-787
53. Scherer A., Salathé M., and Bonhoeffer S. High epitope expression levels increase competition between T cells. PLoS Comput. Biol. 2 8 (2006) e109
54. Seiden P.E., and Celada F. A model for simulating cognate recognition and response in the immune system. J. Theor. Biol. 158 3 (1992) 329-357
55. Shahaf G., Johnson K., and Mehr R. B cell development in aging mice: Lessons from mathematical modeling. Int. Immunol. 18 (2005) 31-39
56. Sotiropoulou P.A., Perez S.A., Voelter V., Echner H., Missitzis I., Tsavaris N.B., Papamichail M., and Baxevanis C.N. Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors. Cancer Immunol. Immunother. 52 12 (2003) 771-779
57. van Stipdonk M.J., Hardenberg G., Bijker M.S., Lemmens E.E., Droin N.M., Green D.R., and Schoenberger S.P. Dynamic programming of CD8+ T lymphocyte responses. Nat. Immunol. 4 4 (2003) 361-365
58. Varela F.J., and Stewart J. Dynamics of a class of immune networks: Global stability of idiotype interactions. J. Theor. Biol. 144 (1990) 93-101
59. Weisbuch G., DeBoer R.J., and Perelson A.S. Localized memories in idiotypic networks. J. Theor. Biol. 146 4 (1990) 483-499
60. Wodarz D., and Thomsen A.R. Effect of the CTL proliferation program on virus dynamics. Int. Immunol. 17 9 (2005) 1269-1276